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PART I: General introduction. 
 
1. DENGUE VIRUS 
1.1. Introduction  
Dengue fever is a serious health problem worldwide, the global distribution is estimated 
to be over 100 countries (Slifka, 2014). In 2009 the World Health Organization (WHO) 
estimated 50 million cases per year reported in 2009 (WHO W. H., 2009), however 
recent studies have suggested global infection at closer to 390 million infections per 
year (Bhatt S., 2013). This phenomenon may be related to the vector´s adaptation to 
different climates and ecosystems (Gubler, 1998). 
The causative agent of dengue fever is dengue virus belonging to the genus Flavivirus, 
family Flaviviridae, there are four dengue serotypes appointed from Dengue-1 to 
Dengue-4 (Gubler, 1998).  These serotypes differ based on the envelope protein (E) and 
different serotypes vary approximately 30% in the polyprotein (Tuiskunen A., 2013). 
Infection with dengue virus may be asymptomatic or present varied symptoms as a flu-
like syndrome and correspond to dengue fever (DF), severe cases present coagulopathy, 
increased vascular fragility and permeability and correspond to dengue hemorrhagic 
fever (DHF). Some cases progress to hypovolemic shock and result in dengue shock 
syndrome (DSS) (Martina B., 2009). 
 
1.1. Structure and replication cycle. 
The virus consists of a single strand of RNA, approximately 11Kb, this nucleic acid is 
surrounded by isometric icosahedral nucleocapsid of approximately 30nm in diameter. 
The envelope around 10nm in diameter and completing a diameter of about 50nm. The 
virus comprises structural proteins such as core or nucleocapsid protein (C), membrane 
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associated proteins (M) and envelope proteins (E) (Henchal R., 1990). Proteins come 
from a single polypeptide precursor. Seven non-structural proteins (NS1, NS2A, NS2B, 
NS3, NS4A, NS4B and NS5) are products of viral translation. (Fig 3) (Martins S., 
2012).  
 
 
Figure 3: Scheme of dengue virus genome (Vasilakis N., 2011). 
 
The genome consists of two terminal untranslated regions at the 5` and 3` ends of the 
genome. These have secondary structures that confer different functional structures and 
have high sequence conservation between different dengue serotypes. The cellcycle of 
the virus starts with viral attachment to cell surface receptors and entry by endocytosis. 
Due to the pH of the endosome, viral glycoproteins fuse to the endosome membrane and 
release viral RNA in the cytoplasm. The viral RNA (as mRNA) is translated directly 
and produces a polyprotein. Non-structural proteins allow viral genome replication. 
Virus assembly occurs in the endoplasmic reticulum to form immature particles, where 
they are carried through the acidic environment of the Golgi network. The prM protein 
leads to the maturation of the virus and is released from the cell (Tuiskunen A., 2013). 
 
1.2. Epidemiology 
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It is thought likely that major epidemics occurred in Asia, Africa and North America in 
1779 and 1780. However, old records describe cases clinically compatible with dengue 
in China 610 A.D. An ecological disorganization was observed in the areas of Southeast 
Asia and Pacific during and after World War II, where appropriate conditions for the 
transmission of mosquito-borne diseases initiated global pandemic of dengue. In the 
1970s cases were observed in the Pacific Islands and subsequently in the Americas.  
In the, 1980-1990 period there was a global increase of dengue cases enlargement of the 
geographical distribution and mosquito populations, and icreases in  virus diverstity and 
disease severity (Gubler, 1998). 
Considering the data from 2010, from 96 million dengue infections, 66.8 million were 
from Asia, 15.7 from Africa and 13.3 million were from Americas (Table1) (Bhatt S., 
2013).   
 
Table 1: Estimated burden of dengue in 2010, by continent (Bhatt S., 2013). 
  Apparent Unapparent 
 
Millions (credible interval) Millions (credible interval) 
Africa 15.7 (10.5-22.5) 48.4 (34.3-65.2) 
Asia 66.8 (47.0-94.4) 204.4 (151.8-273.0) 
Americas 13.3 (9.5-18.5) 40.5 (30.5-53.3) 
Oceania 0.18 (0.11-0.28) 0.55 (0.35-0.82) 
Global 96 (67.1-135.6) 293.9 (217.0-392.3) 
 
The earliest records of dengue in Ecuador is evidence in 1980, along with Brazil, 
Bolivia, Paraguay and Peru, explosive epidemics of DENV-1 were presented. After the 
introduction of DENV-1 major epidemics in Brazil, Ecuador and Peru are recorded 
(Pinheiro F., 1997). In the years 2000-2010 presented an increase in cases of Dengue in 
the Americas, with the four serotypes. In 2000 Ecuador presents an outbreak of 22,937 
cases with 6,117 cases of dengue hemorrhagic fever (Fig. 1) (Brathwaite Dick O., 
2012). 
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Figure 1: Number of dengue cases Ecuador in 1995–2010 (Brathwaite Dick O., 2012). 
 
In Ecuador, there was a reduction in cases of approximately 27% between 2012 and 
2013. In 2013, 11,662 new cases of dengue were confirmed, of which, 10,560 (90.6%) 
were dengue without warning signs were recorded (defined according to the MSP 
patients with symptoms of “dengue fever”: fever, headache, pain behind the eyes, 
muscle aches, decay and eventual redness and itching of the skin); 1,042 (9%) were 
cases of dengue with warning signs (defined according to the MSP patients with 
symptoms like: severe abdominal pain, difficulty breathing, persistent vomiting, minor 
bleeding, lethargy or irritability) and 60 (0.52%) cases with severe dengue (defined 
according to the MSP patients with drop in blood pressure to the shock, fluid 
accumulation in the lungs, severe bleeding and damage to various organs) (MSP, 
www.salud.gob.ec, 2013). It should be noted that many asymptomatic cases are not 
reported and do not appear in the statistics of the Ministry of Public Health.  
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Currently, cases of dengue are distributed mostly along the Ecuadorian coast. In 2014,  
the highest number of cases found in the province of Guayas (Fig. 2) (MSP, 
www.salud.gob.ec, 2014) (MSP, www.salud.gob.ec, 2014). 
 
 
Figure 2: Map of severe dengue distributed by provinces in 2014 (MSP, 
www.salud.gob.ec, 2014). 
 
1.3. Transmission 
Dengue virus (DENV) is transmitted by the bite of the mosquito, Aedes aegypti. Cases 
of dengue fever have been recorded following the bite of Aedes albopictus y Aedes 
polynesiensis mosquitoes, the spread of the disease depends very much on the 
distribution of the vector. In tropical climates the mosquito develops in places where 
water is stagnant for several weeks, especially after accumulation of rainwater. It has 
also been observed that eggs can remain viable for several months in the absence of 
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water (WHO W. H., Prevention and Control of Dengue and Dengue Haemorrhagic 
Fever, 2009). 
After an infected adult female bites a human, the virus is introduced and the symptoms 
will start after an incubation period of 3-14 days, the disease include fever and 
nonspecific symptoms. During fever spikes, the virus is circulating in peripheral blood 
and could be the source of infection of another mosquito feeding on the patient (Gubler, 
1998). Once blood is ingested, it reaches the midgut of the mosquito, the virus binds to 
receptors of the midgut cells where it replicates and the new viruses pass to the 
hemocoel and spreads to the salivary glands from where it is shed with the saliva during 
the blood-meals (Carrington L., 2014). Many factors influence a successful transmission 
of the virus, the level of viremia is a determining factor of virus transmission. It has 
been observed that patients with higher viral loads have a greater window of infectivity 
compared to those with low levels of viremia. (Nguyena N., 2013). It is thought that 
cases 290 million each year are presented in asymptomatic way, suggesting that 
contribute to the continued transmission of dengue, especially in endemic areas 
(Carrington L., 2014). 
 
1.2. Pathogenesis and Virulence 
Several investigations have been carried out in order to understand  why some patients 
develop classical dengue while others develop a life-threatening hemorrhagic disease. 
Many studies have shown that pre-existing humoral immunity enhance dengue 
dissemination. This process is called antibody-dependent enhancement (ADE), it 
increases the number of infected cells (Flipse J., 2013).  
The cell tropism of dengue virus plays an important role in the pathogenesis of the 
disease. Initially the virus is injected into the epidermis/dermis, therefore the first 
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infected cells are Langerhans cells (epidermal dendritic cells –DC-) and keratinocytes. 
These infected cells migrate to lymph nodes, where other cells become infected 
(monocytes and macrophages). The infection spreads through a wide variety of infected 
immune cells. Some postmortem studies of patients that died from dengue fever have 
presence of dengue virus in in skin, liver, lymph node, spleen, kidney, thymus, lung 
bone marrow and brain. The virus can also be isolated from liver and peripheral blood 
mononuclear cells. Apoptosis was detected in endothelial cell in intestinal and lung 
tissues in cases of DHF/DSS. Perhaps this explains profound plasma leakage in 
peritoneal and pleural cavities (Martina B., 2009).  
Different virulence has been associated to dengue serotypes and other genetic 
differences among dengue viruses. It has been observed that the emergence of new 
circulating serotypes was associated with severe cases of dengue (Martina B., 2009).  
It was possible to observe a relationship between virulence and geography. Based on 
these cases, it was determined that increases virulence was connected with more 
pathogenic DENV strains circulating in specific populations, and the ability to infect 
specific cell types such as macrophages of dendritic cells (DC). For example titers of 
DENV-2 in human DCs is higher in South East Asian viruses than American ones 
(Tuiskunen A., 2013) and the ability of DC to interact with the replication of the virus 
may be associated with the development of DHF or DSS. It has been observed that 
dengue virus non-structural proteins NS5, NS4B and NS2B-NS3 complex can inhibit 
type I IFN (cytokine that can be produced by DC infected with dengue), which 
compromises the innate immune response. Chemokine produced by infected DC can 
contribute to the plasma leakage and local inflammation and it cans contribute to the 
vascular leakage with secreted metalloproteinases (Martins S., 2012)  
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It has been observed that dengue virus influences activation of apoptosis has an 
important role in the viral life cycle and may contribute to dengue pathogenesis. (Ghosh 
R., 2014). In summary, virulence may vary according to viral phenotype and host 
immunity status (Martina B., 2009). 
 
1.3. Host immune factors 
The immune response plays an important role in development of the disease in at DH 
and DSS role. (Tuiskunen A., 2013). Mediators including cytokines tumor necrosis 
factor (TNF), interleukin-1 (IL-1), IL-2, IL-6, platelet-activating factor (PAF), 
complement activation products C3a and C5a, and histamine are all thought to be 
involved in of the severity of the disease. CD41 T lymphocytes produce cytokines such 
as interferon gamma (IFN-g), IL-2, IL-4, IL-5, IL-6, IL-10, and lymphotoxin. These 
mediators and cytokines induce the production of other cytokines, which can result in 
vascular permeability effects (Gubler, 1998). 
NSI is thought to activate complement protein and fewer anti NS3 and NS5 protein 
antibodies. However, the spread of the disease can also thank antibodies, especially 
when another serotype subsequently infects a previous infection, increasing the risk of 
serious illness, because as was explained in ADE, these antibodies bind to partially 
another serotype antigen, rather allowing free access to more cells and increase the 
infection (Tuiskunen A., 2013). 
Dengue antibodies can activate complement fixation as a favorable virions and 
inhibition of viral infection. However, again this can be detrimental because the 
increase of complement in the endothelial surfaces may contribute to vascular leak and 
this action has been related to plasma loss relating complement as a trigger factor for 
DHF (Tuiskunen A., 2013). 
16 
 
  
As regards the cellular response is also crucial in the pathogenesis of dengue, similarly 
that the humoral response is considered protective or deleterious in some cases. The 
dengue virus can infect both CD4 T cells and CD8, in the case of low affinity for the 
current infecting virus and high affinity for a previous infection, results in altered 
between protection and disease pathology balance (Tuiskunen A., 2013). 
 
1.4. Diagnosis  
Detection of viral RNA by RT- PCR in whole blood, serum, plasma or cellular material 
is useful only in the early stages of disease. This technique can be easily developed in 
comparison with cell culture, however care must be taken in the collection and 
maintenance of the samples. Detection of anti-DENV antibodies can acts as a tool in 
places where access technologies such as PCR is not possible and when the patient is no 
longer viremic. IgM antibodies can be detected in the acute phase of the disease and 
IgG for several years later. The limitation is false positive results due to cross-react with 
other flaviviruses, such as patients vaccinated against yellow fever virus (Tuiskunen A., 
2013). There are also methods of diagnosis by enzyme-linked immunosorbent assay 
(ELISA) for detection of the NS1 protein up to 9 days after infection. The amount of 
NS1 in serum is relative to dengue viremia. It has proven a useful assay in patients 
where IgM is not detectable or RT-PCR is not available. The sensitivity of this test 
depends on the time of completion of the test, and whether serotype DENV infection is 
primary or secondary (Tuiskunen A., 2013). 
 
1.5. Vaccine 
There are several risks in the development of a vaccine for dengue, one is that immunity 
to some dengue virus serotypes may enhances the severity of the disease caused by 
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other serotypes. The vaccine should be protective for the four serotypes of dengue and 
should generate an effective immune response to all four serotypes simultaneously. It is 
important to assess vaccine effectiveness in patients who have been infected with other 
flaviviruses and those who have not had contact with flavivirus, it is particularly 
important in areas were dengue and other flaviviruses are endemic (Thisyakorn U, 
2014). It was observed that ADE may intervene in the effectiveness of attenuated 
vaccines interfering especially when increased levels of viremia after immunization. 
Also has been observed that different levels of neutralizing antibodies against different 
serotypes are generated. Therefore development of live vaccines is also a challenge for 
health systems, especially in developing countries, to reach the right dose at the time of 
vaccination (Ghosh A., 2015). There are currently several challenges for the 
development of an effective vaccine for all four serotypes, in the following  
 
Currently there are different candidate dengue vaccines: live attenuated virus vaccines, 
live chimeric virus vaccines, inactivated virus vaccines, live recombinant, viral-vectors 
DENV antigens, subunit vaccines and DNA. The development of these vaccines is vital 
to combat the disease whereas vector control has had limited success in reducing the 
transmission of dengue (Ghosh A., 2015).  
 
Table 2: Current development of vaccines for dengue (Ghosh A., 2015). 
Type of vaccine Phase of 
clinical trial 
Developer/Manufacturer 
Cell culture passage based lived 
attenuated viruses (Tetravalent 
vaccine) 
II Walter Reed Army Institute of Research 
(WRAIR), GlaxoSmithKline Biologicals 
Yellow fever-DENV chimeric 
viruses (Tetravalent vaccine) 
III National Institutes of Health (NIH) and St. 
Louis University Health Science Centre, 
Sanofi Pasteur 
Mixture of cell culture passage based 
attenuated virus and dengue-dengue 
intertypic chimeric viruses 
(Tetravalent vaccine) 
II Inviragen Inc. 
Mixture of targeted mutagenesis I National Institute of Allergy and Infectious 
18 
 
  
based attenuated viruses and dengue-
dengue intertypic chimeric viruses 
(Tetravalent vaccine) 
Disease (NIAID), National Institutes of 
Health (NIH), Bustantan Institute 
Purified inactivated dengue vaccine 
(Tetravalent vaccine) 
I WRAIR, GlaxoSmithKline Biologicals, 
Oswaldo Cruz Foundation Merck and Co 
Recombinant subunit vaccine 
(Monovalent vaccine) 
I Merck and Co. 
DNA vaccine expressing prM and E 
protein (Monovalent vaccine) 
I Naval Medical Research Centre, Walter 
Reed Army Institute of Research (WRAIR) 
 
Finally, there are many challenges in developing an effective vaccine for the four 
serotypes of dengue, and if necessary the existence of a new serotype. Through a series 
of regulations can be determined one vaccination as a preventive measure and control 
strategies vectors could resist the annual global burden of dengue (Ghosh A., 2015). 
 
2.1. Treatment 
Symptoms of dengue fever are resolved in most cases from 3 to 7 days post infection, 
however when it comes to severe dengue, which can be a hypovolemic shock or 
hemorrhagic, patient management includes vasopressors and replacement electrolytes to 
take care of fluid loss by vascular permeability, and in some cases use of blood products 
is required. There is a need to develop a therapies so that development of the disease 
and severe complications are reduced: this can be achieved by treatments or antivirals. 
However the major challenge is the complexity of dengue, especially in endemic areas 
(Whitehorn J., 2014). 
 
 
2. LEPTOSPIRAL INFECTION 
2.1. Introduction  
Leptospires are spirochetes, 0.1μm by 6 to 0.1 by 20μm. The lipopolysaccharide has a 
low endotoxic activity. Leptospira are aerobic they are catalase and oxidase positive, 
and grow in laboratory from 28 to 30ºC.  
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Leptospirosis is a zoonosis distributed worldwide, especially in developing countries. 
Infection occurs by contact with infected animal urine or water contaminated with urine 
from domestic or wild animals. The bacterial entry to the host occurs through skin cuts,  
conjunctives, skin submerged in water for long time. The bacteria is maintained in 
nature in the renal tubules of animal carriers which are mammals like rats, dogs, etc. 
There is an occupational risk for leptospirosis in people who are in direct contact with 
animal or animal tissues. However infection in the urban environment occurs through 
rodents, especially in developing countries where sanitary infrastructure is inadequate 
(Levett, 2001). 
 
2.2. Epidemiology 
Leptospirosis is common in tropical and subtropical areas, and the presence of the 
disease has more impact with high rainfall. According to Leptospirosis Burden 
Epidemiology Reference Group (LERG) at the World Health Organization estimated 
500,000 cases of leptospirosis per year. However, the poor surveillance and difficult 
diagnosis do not estimate a real number of cases (Lehmann J., 2014).  
The incidence estimated is 0.1-1 per 100,000 per year in temperate climates and 10-100 
per 100,000 in the humid tropics. In high risk groups or during outbreaks the incidence 
may reach over 100 per 100,000 (WHO W. H., Human leptospirosis : guidance for 
diagnosis, surveillance and control., 2003)  
In Ecuador leptospirosis behaves as an endemic disease with epidemic outbreaks, being 
observed in urban and rural areas. One of the first reports of L. noguchi was in 1918, 
since it is reported Leptospira second time in 1932 (Quinga L., 2010). Outbreaks have 
occurred in 1998, in 2012 and 2013 (Fig. 4 and 5) (MSP, www.salud.gob.ec, 2014).  
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Figure 4: Number of leptospirosis cases Ecuador in 1994–2014 (MSP, 
www.salud.gob.ec, 2014). 
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Figure 5: Map of leptospirosis cases by province in 2014 (MSP, www.salud.gob.ec, 
2014). 
2.3. Diagnosis 
The typical symptoms of leptospirosis are fever, chills, headache, abdominal pain, 
conjunctival effusion and these representing an undifferentiated febrile illness. The most 
frequent disease is anicteric leptospirosis which shows elevated erythrocyte 
sedimentation and a small elevation of aminotransferases, bilirubin and alkaline 
phosphatase. The disease can be fatal with renal failure, jaundice hemorrhage 
(particularly in the lungs) and vascular collapse. In urine samples can be observed 
proteinuria, pyuria and microscopically observed hematuria (Lehmann J., 2014).  
Leptospira can be observed in dark-field microscopy, but require large numbers of 
leptospires per optical field in order to be detected. Direct inmunofluorescense can be 
used in urine, water, soil and blood. Histophatological techniques include 
immnoperoxidase (immune-histochemistry) and silver stain. During the first 5 days of 
the disease leptospires can be found in blood (Levett, 2001).   
For the detection of antigens was evaluated radioimmunoassay (detection of 104 to 105 
leptospires/ml) and ELISA (detection of 105 leptospires/ml). For cultures, samples 
should be processed as soon as possible, leptospires survive a few days and rarely 
recover after the initial symptoms. Also we can grow urine from the second week of 
symptomatic disease (Levett, 2001).  
Within 5 to 7 days after the onset of symptoms, the diseases can be diagnosed by 
serology and the gold standard technique is microscopic agglutination test (MAT); for 
this technique patient serum reacts with suspensions of different strains of Leptospira 
and examined microscopically for agglutination. This method is complex and requires 
experienced personnel additionally the maintenance of live cultures involves the risk of 
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infection. Agglutination results are affected by the culture medium where the antigens 
grow. There is cross-reactivity (among leptospire serovars) in the acute phase of the 
disease, and increased specificity during the convalescent phase. The MAT detects both 
IgM and IgG antibodies. In most places, detection of antileptospiral IgM is carried out 
by ELISA. Other techniques are less used such as immunoflurescence, RIA, 
counterimmunoelectrophoresis and thin-layer immunoassay (Levett, 2001).  
 
2.4. Genetic characteristics and microbiological 
Leptospira genome size is 5000 kb approximately, two parts comprising the genome, 
one chromosome size is 4400 kb and one smaller size is 350 kb. Leptospira was 
observed two sets of genes for 16s and 23s RNA and a set of genes for 5s. It also has 
insertion sequences (IS) encoding transposases (Levett, 2001).  
Initially leptospires are grouped into two species L. interrogans sensu lato(pathogenic 
strains) and L. biflexa sensu lato (saprophytic strains). Based on agglutination reaction 
with specific antigens leptospires are divided into numerous serovars, 60 serovars of L. 
biflexa and more than 200 serovars of L. interrogans (sensu lato) were identified 
(Levett, 2001). 
Additionally, leptospires are grouped into serogroups all antigenically related serovars 
and this classification into serogroups are useful for more than taxonomic 
epidemiological understanding (Levett, 2001). 
Based on core genes phylogeny, the genus Leptospira in 21 species which form three 
groups: pathogens, intermediate pathogens and saprophytes; pathogens and 
intermediates are associated to animal infections  (Fig. 6) (Lehmann J., 2014). 
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Figure 6: Phylogenetic tree representing the taxonomy of the genus Leptospira 
(Lehmann J., 2014). 
 
2.5. Pathogenesis and virulence 
Animal reservoirs are colonized (and may remain infected for life) by Leptospira in the 
renal tubules and this bacterium is excreted via urine to the environment. However, 
infected animals including humans can remain colonized by Leptospira for a few 
months, even a year or more in the case of pathogenic and intermediate Leptospira 
(Lehmann J., 2014).   
The gain or loss of genes are important for understanding virulence and pathogenesis of 
bacteria. Among the factors that increase the virulence of Leptospira are the mobile 
genetic elements. Some examples are found in Leptospira: transposons, prophages, 
genomic islands, insertion sequence (IS) elements. These elements can encode 
important molecules for colonization, invasion of niches, use of substrates, or evasion of 
the host immune response. In Leptospira not much is known about the mechanisms of 
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pathogenicity. Few factors have been associated to virulence such as  LPS, flagellum, 
heme-oxygenase, adhesion molecules and the OmpA-like protein Loa22. Specifically 
sphingomyelinases and hemolysins have an important role during infection (Lehmann 
J., 2014). 
Leptospira genes acquired through prophage were observed and have an influence on 
the differentiation of pathogenic leptospires. The prophage LE1 (BB-LiZ_VAR010-
LE1) found in L. licerasiae, encode an efflux pumps, these proteins are homologous to 
those found in pathogenic leptospires and are absent in saprophytic leptospires like L. 
biflexa; the presence of these genes may suggest the adaptation to mammalian host 
(Lehmann J., 2014). 
Within elements that are transferred via plasmids found the type II and type III toxin-
antitoxin systems (TAS), to which have been attributed various functions ranging from; 
no functional roles (remaining of chromosomes, transposons and bacteriophages) and 
functional roles (gene regulation, programmed cell death and anti-phage activity). The 
mobile genetic elements may be associated with unknown ecological adaptations of 
Leptospira. For example; L. licerasiae has three types of unique type III TAS in this 
genus. L. interrogans has five TASs compared to L. biflexa, it should be emphasized 
that these five TASs, four are unique to L. interrogans (Lehmann J., 2014).   
When analyzing the O-antigen (rfb) shows an important idea of the determining factors 
for adaptation in the host. Understanding the evolution of O-antigen serotypes could 
clarify emergence and transmission cycles (Lehmann J., 2014). 
Genomic comparison between Leptospira species show that L. biflexa has few 
transposable elements, and reduced metabolic functions solute transport systems when 
L. borgpetersenii, is compared L. interrogans, L. interrogans has more signal 
transduction systems, metabolic genes, transcriptional factors and solute transport 
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systems, all this be related to survival in the environment, which facilitates transmission 
(Lehmann J., 2014).  
Based on functional content and amino acid sequences shows that L. licerasiae 
(intermedia group) is genetically more related to pathogenic leptospires than 
saprophytic Leptospira (Fig.7) (Lehmann J., 2014).  
 
 
Figure 7: Proteins diagram between different species of Leptospira (Lehmann J., 2014). 
 
2.6. Vaccines 
Until now there has not been one a vaccine for humans. Some proteins are candidates 
for vaccine development, for example: proteins of adhesion to I and IV collagens, 
laminin, fibronectin and fibrinogen. The latter are important in certain bacterial 
infections, are widely conserved can be important for each candidate vaccine 
development (Lehmann J., 2014).  
 
2.7. Treatment 
The treatment of leptospirosis in the first like-flu symptoms do not require further 
treatment, however patients with more severe disease, who are jaundiced may require 
hospitalization. With doxycycline for seven days have been good results. By way of 
prophylaxis prescription doxycycline 200 mg for a week (Levett, 2001).  
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PART II: Detection of Leptospirosis and Dengue in Patients with Acute 
Undifferentiated Febrile Illness in the Northern Coast of Ecuador. 
 
ABSTRACT 
In this study the presence of two important developmental diseases in tropical areas are 
detected, such as: Dengue and Leptospirosis. A total of 251 was collected in serum and 
blood spots on filter paper between February 2011 and March 2013. Just over half 
(52.78%) of serum samples from febrile patients who sought medical attention in local 
hospital were PCR positive for leptospirosis, 4.62% were positive for dengue alone, 
26.86% were positive for both leptospirosis and dengue, and 15.74% were negative for 
both agents. 
Blood samples were obtained from 102 febrile patients were 78,43% positive for 
Leptospira, 1.96% were PCR positive for both dengue and leptospirosis, 19 60% were 
negative and no patient was positive for dengue alone. 
Our results showed that DENV-1, DENV-2 and DENV-3 serotypes were present in the 
area. One hundred forty five potential leptospiral amplicons were sequenced, 3 products 
belonged to pathogenic Leptospira noguchii, 136 were identified as Leptospira wolfii, 
and 6 were undetermined. 
 
Keywords: Dengue, intermediate Leptospira, ELISA, RT-PCR, qPCR, Serotype. 
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RESUMEN 
En el presente estudio se detectó la presencia de dos enfermedades de importante 
desarrollo en áreas tropicales, como son: Dengue y Leptospirosis. Se recolectó un total 
de 251 en suero y manchas de sangre en papel filtro entre febrero de 2011 y marzo de 
2013. Poco más de la mitad (52,78%) de las muestras de suero de pacientes febriles que 
buscaron atención médica en el "Hospital Civil de Borbón", fueron PCR positiva para la 
leptospirosis, 4,62% fueron positivos para dengue solo, 26,86% fueron positivas tanto 
para la leptospirosis y el dengue, y 15.74% fueron negativos para ambos agentes. 
Muestras de sangre en papel filtro de 102 pacientes febriles fueron 78,43% positivos 
para leptospirosis, 1,96% positivas para el dengue y Leptospira, 19,60% fueron 
negativas para los dos agentes y ningún paciente fue positivo únicamente para el 
dengue. 
Las reacciones de RT-PCR mostró que DENV-1, DENV-2 y DENV-3 serotipos estaban 
presentes en la zona. 
Ciento cuarenta y cinco productos de PCR para Leptospira fueron secuenciados; tres 
productos pertenecían a Leptospira noguchii, 136 fueron identificados como Leptospira 
wolfii. 
 
Palabras clave: Dengue, Leptospira intermedia, ELISA, RT-PCR, qPCR, Serotipo.   
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INTRODUCTION 
Dengue fever is a mosquito-borne disease that has rapidly distributed throughout the 
world. An estimated 50 million dengue infections occur annually and approximately 2,5 
billion people live in dengue endemic countries. Dengue fever is caused by one of the 
four serotypes of dengue virus (serotypes 1-4). Humans, lower primates and Aedes 
mosquitoes are host of dengue virus (McBridea W., 2000).  
The history of dengue in Ecuador started in 1988 when DENV 1 was detected for the 
fist time, in 1990 DENV 2, in 1993 DENV 4 and in 2000 DENV 3 (Alava A, 2005). 
From 2001 to 2007, the countries present in Andes zone accounted for 19% of all case 
of dengue in the Americas. It is the subregion with the highest number of dengue 
hemorrhagic fever (DHF) cases in the Americas (WHO W. H., 2009).  
 
Leptospirosis is a bacterial zoonosis caused by a pathogenic spirochete from the genus 
Lesptospira. The disease is maintained in nature through the chronic asymptomatic 
renal infection of several mammals and the bacterium is shed in their urine to the 
environment. Human infection results from either direct contact with the urine of an 
infected animal or indirectly through contact with contaminated water or soil (Ellis T., 
2008). Annually, tens of millions of human cases occur worldwide, with case fatality 
rates ranging as high as 20% - 25% in some regions (Ganoza C, 2006). 
 
Leptospirosis and dengue often have similar clinical manifestation and are among the 
most common diagnostic dilemmas. Both typically occur during the rainy season, and 
rapid laboratory confirmation of the infecting pathogens is not available. Several studies 
have shown that leptospirosis is often confused with dengue and underdiagnosed in 
endemic regions (Libraty D., 2007) (Navarrete J., 2006) (Levett P., 2000) (Behera B., 
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2012). The aim of this study was to assess the frequency of dengue and leptospirosis in 
rural communities of the northern coast of Ecuador.  
 
MATERIALS AND METHODS 
Febrile patients of a broad range of ages from 49 communities in the northern Coast of 
Ecuador were part of the research (Figure 1 and 2). All the participants accepted an oral 
informed consent approved by Institutional Review Board of University of Michigan 
and bioethics committee of Universidad San Francisco de Quito.  
A total of 251 sera (108) and blood spots (143) samples from febrile patients were 
collected between February 2011 and March 2013, 111 patients (44.22%) were male, 
109 (43.42%) were female and 31 (12.35%) were samples in which gender information 
was not provided. Age distribution of the patients was as follows: 23.9% 0 to 15 years 
old, 28.29% were 16 to 30 years old, 15.14% were 31 to 45 years old, 8.37% were 46 to 
60 years old, 3.59% older than 60 years old and 20.72% no age data was obtained 
(Figure 3).  
Sera were tested by RT-PCR and IgM ELISA rapid test for dengue (Panbio,USA). 
ELISA was carried out by laboratory personnel at local hospital. While, blood spots 
samples were analyzed by RT-PCR for dengue only. Both sera and blood spots were 
analyzed for Leptospira by PCR  (Table 1 - 2).  
The serum samples and blood spots, from febrile patients were collected by the Borbón 
Hospital laboratory and Health Ministry personnel, respectively. Serum samples were 
stored at -20ºC, then transported in liquid nitrogen to Quito. Blood spots from febrile 
patients were collected on filter paper (Whatman 93 Specimen Collection Paper), dried 
at room temperature and stored at -20ºC in a zipper bag.   
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RNA extraction 
For blood spots, 2-6 punches (6mm diameter) were collected in a 1.5 ml 
microcentrifuge tube and eluted with 400 μl of RNase free water at 37ºC for 30 min; 
250 μl of human serum samples or eluate from blood spots were mixed with 750 μl of 
Trizol (Ambion by life technologies, Cat. 10296-010) and 200 μl of chloroform and 
kept at -20ºC for 10 min. The mixture was centrifuged at 4ºC for 15 min at 15000 x g 
and the aqueous phase (400 μl) was removed and combined with an equal volume of 
isopropanol to precipitate the RNA. The mixture was kept at -20ºC for 10 min and 
centrifuged at 4ºC for 25 min at 15000 x g. After centrifugation, the resulting RNA 
pellet was washed with 1 ml of 75% ethanol and centrifuged at 4ºC for 5 min at 15000 x 
g. The pellet was dried for 1 hour and dissolved in RNase free water (25-30 μl) and 
stored -80ºC before used. For controls we used cell culture supernatant of DENV-1-4, 
the RNA extraction was made with 50 μl of supernatant. 
 
DNA extraction 
DNA was extracted using QIAamp DNA Mini Kit following instructions from Blood 
Mini Handbook (QIAGEN, USA), 2-6 blood spots punches were incubated with 180 μl 
of ATL buffer for 10 minutes at 85ºC, all the liquid was placed in a new 1.5 ml 
microcentrifuge.  
For serum samples 200 μl were centrifuged for 15 min at 15000 x g (Queipo M., 2008), 
the supernatant was discarded and the pellet was resuspended with 180 μl of buffer 
ATL.  
Eluates from blood spots and the resuspended serum pellet were mixed with 20 μl of 
proteinase K stock solution and incubate at 56ºC for 3 hours in shaking water bath. 
Then 200 μl of buffer AL was added and mixed and incubated at 70ºC for 10 min. 
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Finally, 200 μl of ethanol was added and the mixture was applied to the spin column. 
Wash steps were performed according to the manufacturer’s instructions by using AW1 
and AW2 buffers (Quiagen, USA). DNA was eluted with 50 μl of AE buffer and 
divided in 5 aliquots. Eluted DNAs were stored at -80ºC until use.  
 
DNA Amplification by real-time PCR 
The reaction mixture consisted of 5 μl IQTMSYBR Green supermix, 0,5 uM of each 
primer AB/CD, 3 μl of DNase-free water (GIBCO), 1 μl of DNA extract, in a final 
volume of 10 μl. Primer sequences are as follows:  A, 5’-GGC GGC GCG TCT TAA 
ACA TG; B, 5’-TTC CCC CCA TTG AGC AAG ATT; amplification products are 
333bp and C, 5’-CAA GTC AAG CGG AGT AGC AA; D 5’-CTT AAC CTG CTG 
CCT CCC GTA; amplification products are 292bp (Merien F., 1992) 
PCR was performed in a CFX96 BioRad Hercules USA termal cycler. The first cycle 
consisted of initial denaturation at 95°C for 3 min. The next 45 cycles consisted of 
denaturation at 95°C for 30 s, annealing at 62.5°C for 30s and extension at 72°C for 
30s), an additional 30 s was included for final extension. Finally a melting curve was 
generated by reducing from 65°C to 95°C with a ramp of 0.5°C/5s. 
 
Reverse Transcription and PCR Amplification (RT-PCR) 
The reverse transcription reaction contained 12.5 μl of reaction mix 2x (SuperScript III 
One-Step RT-PCR System, Invitrogen Life Technologies), 0.2 mM of each primer, 
4U/μl Taq Platinum (SuperScript®III RT/Platinum®Taq Mix, Invitrogen Life 
Technologies), 4.2 μl of RNA extract, in a final volume of 25 μl. Primer sequences are 
as follows: D1, 5’-TCA ATA TGC TGA AAC GCG CGA GAA ACC G; TS1, 5’-CGT 
CTC AGT GAT CCG GGG G; TS2, 5’-CGC CAC AAG GGC CAT GAA CAG; TS3, 
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5’-TAA CAT CAT CAT GAG ACA GAG C; and DEN4, 5’-TGT TGT CTT AAA 
CAA GAG AGG TC (Harris E., 1998). 
Reverse transcription was conducted at 52ºC for 1 hour for reverse transcription was 
followed by 40 cycles of 94ºC for 30 s, 55ºC for 1 min, 72ºC for 2 min, with a final 
extension at 72ºC for 5 min. The expected sizes of the amplification products are 482 bp 
(DENV-1), 119 bp (DENV-2), 290 (DENV-3) and 389 (DENV-4) (Harris E., 1998). 
RNA samples were also tested using a housekeeping by β–actin gene amplification.  
 
DNA Amplification by conventional PCR 
Amplification of DNA was performed in a total volume of 25 μl, the reaction mixture 
consisted of 1.5 mM of MgCl2, 0.1 mM dNTP mix, 1x Colorless GoTaq® Reaction 
Buffer (Promega, USA), 0.4 μM each oligonucleotide primer AB/CD, 0.02 U/μl of 
GoTaq® DNA Polymerase (Promega, USA) and 0.2 μl of positive PCR products from 
real time PCR were submitted for conventional PCR.  
The cycle consisted of initial denaturation at 94ºC for 3 min. The next 30 cycles 
consisted of denaturation at 94°C for 1 min, annealing at 63°C for 1,5 min and 
extension at 72°C for 2 min, an additional 10 min was included for final extension. The 
expected PCR products are 333 bp (primer AB) and 292 bp (primer CD). 
 
Visualization of the PCR products was carried out using a 1.6% agarose gel with 
ethidium bromide (0,2 ul/100ml) under UV light. 
 
Sequencing 
39 
 
  
Amplicons from conventional PCR were sequenced at Functional Biosciences 
(Madison, Wisconsin, USA) and analyzed using MEGA5.0 and compared with Basic 
Local Alignment nucleotide tool (Blast).  
 
RESULTS: 
Over half (52.78%) of serum samples from febrile patients who sought medical 
attention at local hospital were PCR positive for leptospirosis, 4.62 % were positive for 
dengue alone, 26.86% were positive for both leptospirosis and dengue, and 15.74% 
were negative for both agents (Table 1).  
Blood spot samples were collected from 102 febrile patients, 78.43% were positive for 
Leptospira, 1.96% were PCR positive for both dengue and Leptospira, 19.60% were 
negative and no patient was positive for dengue alone (Table 2).  
Serum samples were 28.7% ELISA positive for dengue, 1.9% of these were also 
positive by RT-PCR, 0.9% were positive by ELISA and RT-PCR, and 68.5% were 
negative (Table 3). The RT-PCR results showed the presence of three dengue serotypes; 
DENV-1, DENV-2 and DENV-3, within the sampling period in this part of the north 
coast (Table 4) (Figure 4).  
Of the 108 serum and 102 blood spots samples, 169 tested positive Leptospira by PCR, 
145 were sent for DNA sequencing (Functional Biosciences, USA), three products 
showed high homology to pathogenic Leptospira noguchii, 136 were identified as 
Leptospira wolfii species, and 6 were undetermined (Table 4).  
 
DISCUSSION:  
In the present study more than 80% of the patients were positive for Leptospira. 
Previous studies have reported cases of leptospirosis or dengue in patients with acute 
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undifferentiated febrile illness in Ecuador and in other parts of the world (Manock, 
2009) (Acestor N., 2012). Of all samples submitted to sequencing more than 90% were 
identified as Leptospira wolffii, which is part of a leptospiral group mainly associated 
with mild febrile disease (Matthias M., 2008). 
A smaller number of samples (31.3%) showed evidence of dengue virus infection. This 
report shows that DENV-1, DENV-2 and DENV-3 were present in the northern coast of 
Ecuador in 2011, 2012 and 2013. We detected DENV-3, a serotype that has been absent 
in other parts of Ecuador since 2010; but it was detected in the same region in 2010-
2011 (Cifuentes S., 2013). The Colombian Health Ministry has detected DENV-3 
during the time of this study in the southern region (Valderrama, 2013). Therefore we 
speculate that DENV-3 entered Ecuador through the border with Colombia. Human 
travel plays an important role in the geographic distribution of the disease because 
mosquitoes tend to fly short distance (Gubler, Dengue and dengue hemorrhagic fever, 
1997) (Harrington, 2005) (Getis, 2003) (Reiner R., 2014) (Stoddarda S., 2013).  
 
Identification of DENV-3 on the north coast, highlights the importance of identifying 
serotypes circulating in our country, especially in border areas. There are studies in 
which a relationship between the appearance of a new serotype and increased cases of 
DHF or DSS is observed. The authors argue that the appearance of DENV-3 in Africa 
and Latin America is related to outbreaks of DHF, it appears that the endemic genotypes 
of Central and South America cause mild disease, while Asians genotypes produce 
epidemics of DHF (Messer W., 2003). Lanciotti et al. have been identified 
geographically distributed DENV-3 subtypes, where DENV-3 subtype III has been 
found in East Africa, India and Latin America and it has been observed that the 
appearance of this subtype is associated with cases of DHF (Lanciotti RS, 1994). 
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In 2001 Ecuadorian government finished building a road linking the Coast of Ecuador 
with southern Coast of Colombia which may allow travel of dengue patients from 
Colombia to Ecuador and vice versa. Additionally the northern coast of Ecuador has 
been subjected to deforestation and intense ecological disruption (Eisenberg J. N. S., 
2006). Other studies found that deforestation and road construction influenced the 
movement of the mosquitoes to remote regions (Vittor AY, 2006) (Dutta P, 1998).  
 
In this study two patients were positive for dengue by RT-PCR and negative to IgM 
antibodies; RT-PCR is more sensitive to detect early infection of dengue before 
antibodies were generated. Detection of IgM antibodies sometimes does not indicate 
acute infection because this immunoglobulin persists for months (Prince HE, 2011), it 
makes it difficult to distinguish a new infection, and may crossreact with other 
flaviviruses (Senanayake S., 2006) (Teles F., 2005). In this study, 31/108 patients were 
positive for IgM dengue antibodies and negative for RT-PCR. 
 
The evidence of co-infection (leptospirosis and dengue) has been reported previously 
(Levett P., 2000) (Navarrete J., 2006) (Michael G., 2010) (Rele M., 2001) (Crociati L., 
2010) (Behera B., 2012) (Kaur H., 2002). In the present study one patient (0,47%) was 
PCR positive for Leptospira noguchii and had anti-dengue IgM antibodies, 28 patients 
(13,3%) were positive for Leptospira wolffii and dengue (IgM or RT-PCR), these results 
show that co-infections may be common in remote communities. Existence of 
simultaneous infection has been described in immuno-compromised patients, however it 
was found to be uncommon in immune-competent individuals (Behera B., 2012). 
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High presence of leptospirosis in this area may reflect the high reliance on rivers to 
obtain water, personal hygiene and transportation. Other studies showed that it was 
possible to identify high-risk areas for leptospirosis based on environmental variables 
such as deficient sanitary infrastructure, contact with sources of fresh water and 
flooding risk (Lau C., 2012) (Reis R., 2008). 
 
There was no relationship between start of the rainfall and the onset of dengue cases 
(Figure 6). A better relationship was found between rainfall and Leptospira DNA, in the 
blood of febrile patients, the highest peaks of cases of leptospirosis were associated with 
months with heavier rainfall (January to March) (Figure 7). Similar to other studies, 
leptospirosis cases seemed to peak with rainfall (Chadsuthi S., 2012). Rainy seasons are 
known to promote Leptospira infections due to removal of animal urine from soil and 
contamination water sources (Wasinski B., 2013). Several studies have found a direct 
relationship between rainfall and presence of the disease in warm climates (Johansson 
M., 2009) (Chua K., 2005) (Díaz F., 2008) (Senanayake S., 2006).  
 
In this study, 136 out of 145 febrile patients samples had DNA with high similarity to 
leptospires of the intermediate cluster (L. wolffii) and three had DNA with high 
similarity to leptospires of pathogenic cluster (L. noguchii). Another intermediate 
species were found to cause febrile disease in humans (Matthias M., 2008) (Slack AT, 
2008) (Levett PN, 2006) (Arzouni JP, 2002). In our study we did not find any 
leptospiral DNA in samples from non-febrile patients suggesting the involvement of 
intermediate Leptospira in fever. Genome association studies are being conducted to 
identify important genetic differences for the occurrence of species of Leptospira in 
febrile patients (Figure 8) (Lehmann J., 2014) (Slack AT, 2008).  
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In this study Leptospira and dengue seemed to be important etiological agents of fever 
in northern Ecuador; this findings are in agreement with previous studies (Manock, 
2009).  
 
RECOMMENDATIONS 
 To run a study with the highest number of febrile and non-febrile patients 
(controls) in order to determine the prevalence and incidence of Leptospira and 
dengue in Borbón.  
 To do molecular studies on dengue genotypes circulating in the area in order to 
know the origin of DENV-3. 
 To run a study in patients, animals and environmental samples to determine the 
circulating strains of Leptospira in northern coast of Ecuador.  
 To do geographical epidemiological studies in order to anticipate possible 
outbreaks of dengue and Leptospira in this area.  
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TABLES AND FIGURES: 
 
TABLE 1: Reactivity of serum samples for Dengue and Leptospira, from febrile patients*. 
   
 
Positive Leptospira (PCR) Negative Leptospira 
Dengue positive  (IgM or PCR) 29 (26.86%) 5 (4.62%) 
Dengue negative 57 (52.87%) 17 (15.74%) 
   
Total 87 21 
* Patients from Hospital Civil of Borbón. 
 
TABLE 2: Reactivity of blood spots for Dengue and Leptospira, from febrile patients*. 
 
  Positive Leptospira (PCR) Negative Leptospira 
Dengue positive  (PCR) 2 (1.96%) 0 
Dengue negative 80 (78.43%) 20 (19.60%) 
   Total 82 20 
*Patients who were collected by “SNEM” for malaria diagnostic test. 
 
 
TABLE 3: Positive RT-PCR and ELISA dengue cases in serum samples*.   
        
  
               RT-PCR 
  
 
    Positive     Negative 
  
ELISA** 
Positive 1 (0.9%)   31 (28.7%) 
  
Negativa 2 (1.9%)   74 (68.5%) 
  
     
Total 108 
 
*Patiens from Hospital Civil of Borbón. 
   
**ELISA test was carried out by HCB laboratory personnel. 
   
 
 
TABLE 4: Identification of serotypes of Dengue and year. 
      
 
POSITIVE 
Dengue 1 Dengue 2 Dengue 3 Dengue 4 
  RT-PCR/qPCR 
Borbón Hospital 
patients 
5 0 
3 2 
0 
(2012, 2013) (2011, 2013) 
SNEM patients 2 
1 
0 
1 
0 
(2012) (2012) 
 
7 1 3 3 0 
 
 
Table 5.- Identification de Leptospira. 
    
 
Number of samples processed 210   
  
Real time PCR positive 193 
 
  Conventional PCR positive 169 
51 
 
  
 
Number of samples identifies by 
sequencing 
145   
  
Leptospira wolfii 136 
  
Leptospira noguchii 3 
 
  Undetermined 6 
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FIGURE 1: Study sites in the “Cantón Eloy Alfaro” communities and origin of the 
samples (yellow). 
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FIGURE 2: Number of patients for each communities. 
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FIGURE 3: Distribution of age and patients.  
 
 
 
 
 
FIGURE 4: Dengue positive cases (PAMBIO IgM / RT-PCR) in the “Cantón Eloy 
Alfaro” communities. 
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FIGURE 5: Leptospira positive cases in the “Cantón Eloy Alfaro” communities 
(red=pathogenic Leptospira and blue= Intermediate Leptospira). 
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FIGURE 6: Association between precipitation and cases of dengue during 2011 to 
2013. 
 
 
FIGURE 7: Association between precipitation and cases of leptospirosis during 
2011 to 2013 
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FIGURE 8: Dendrogram based on 16S rRNA gene, which is shown Leptospira 
found in Esmeraldas, and representative Leptospira species. The neighbor-joining 
method, bootstrap 500 was used. 
 
 
 
